<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">7801132</journal-id>
<journal-id journal-id-type="pubmed-jr-id">7499</journal-id>
<journal-id journal-id-type="nlm-ta">Semin Perinatol</journal-id>
<journal-id journal-id-type="iso-abbrev">Semin. Perinatol.</journal-id>
<journal-title-group>
<journal-title>Seminars in perinatology</journal-title>
</journal-title-group>
<issn pub-type="ppub">0146-0005</issn>
<issn pub-type="epub">1558-075X</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">26718445</article-id>
<article-id pub-id-type="pmc">4826755</article-id>
<article-id pub-id-type="doi">10.1053/j.semperi.2015.11.007</article-id>
<article-id pub-id-type="manuscript">NIHMS739723</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Pre-and Post-test Genetic Counseling for Chromosomal and Mendelian Disorders</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Allen</surname>
<given-names>Jill Fonda</given-names>
</name>
<degrees>MS, CGC</degrees>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Stoll</surname>
<given-names>Katie</given-names>
</name>
<degrees>MS, LGC</degrees>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bernhardt</surname>
<given-names>Barbara A</given-names>
</name>
<degrees>MS, LCGC</degrees>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
</contrib-group>
<aff id="A1"><label>1</label>Senior Genetic Counselor, Greater Washington Maternal Fetal Medicine and Genetics, Rockville, MD</aff>
<aff id="A2"><label>2</label>Genetic Counselor, Genetic Support Foundation, and Providence Health &amp; Services, Olympia, WA</aff>
<aff id="A3"><label>3</label>Clinical Professor of Medicine and Genetic Counselor, Division of Translational Medicine and Human Genetics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA</aff>
<author-notes>
<corresp id="FN1">Corresponding author: Jill Fonda Allen, MS, CGC, Greater Washington Maternal-Fetal Medicine and Genetics, 9707 Medical Center Drive, #230, Rockville, MD 20850, Phone: 301-279-6060, Fax: 301-279-6345, <email>jill.fonda.cgc@gmail.com</email></corresp>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>2</day>
<month>4</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="epub">
<day>21</day>
<month>12</month>
<year>2015</year>
</pub-date>
<pub-date pub-type="ppub">
<month>2</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>01</day>
<month>2</month>
<year>2017</year>
</pub-date>
<volume>40</volume>
<issue>1</issue>
<fpage>44</fpage>
<lpage>55</lpage>
<!--elocation-id from pubmed: 10.1053/j.semperi.2015.11.007-->
<abstract>
<p id="P2">Genetic carrier screening, prenatal screening for aneuploidy and prenatal diagnostic testing have expanded dramatically over the past two decades. Driven in part by powerful market forces, new complex testing modalities have become available after limited clinical research. The responsibility for offering these tests lies primarily on the obstetrical care provider, and has become more burdensome as the number of testing options expands. Genetic testing in pregnancy is optional, and decisions about undergoing tests, as well as follow-up testing, should be informed and based on individual patientsâ€™ values and needs. Careful pre- and post-test counseling is central to supporting informed decision-making. This article explores three areas of technical expansion in genetic testing: expanded carrier screening, non-invasive prenatal screening for fetal aneuploidies using cell-free DNA, and diagnostic testing using fetal chromosomal microarray testing, and provides insights aimed at enabling the obstetrical practitioner to better support patients considering these tests.</p>
</abstract>
<kwd-group>
<kwd>Genetic counseling</kwd>
<kwd>prenatal diagnosis</kwd>
<kwd>genetic carrier screening</kwd>
<kwd>cell-free DNA screening</kwd>
<kwd>non-invasive prenatal screening</kwd>
<kwd>chromosome microarray</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>